Renaissance Technologies’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Renaissance Technologies’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-131,049	Closed	-$39K	–	4301
2023 Q2	$39K	Sell	131,049 -125,251	-49%	-$37.8K	﹤0.01%	3660
2023 Q1	$111K	Buy	+256,300	New	+$197K	﹤0.01%	3460

Renaissance Technologies's GRNA Position: Q3 2023 in Review

Renaissance Technologies sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 131,049 shares — an estimated $39K sold.

Renaissance Technologies first reported a position in GRNA in Q1 2023 and held it in 2 quarters. The position peaked at $111K in Q1 2023. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Renaissance Technologies reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Renaissance Technologies sold 131,049 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $39K.
Renaissance Technologies first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2023 and held it in 2 quarters.
Renaissance Technologies's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $111K in Q1 2023.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.